Dendritic Cell Vaccination for Glioblastoma Multiforme: Clinical Experience and Future Directions

被引：0

作者：

Dejaegher, Joost ^{[1
,2
]}

Solie, Lien ^{[3
]}

De Vleeschouwer, Steven ^{[1
,2
]}

Van Gool, Stefaan W. ^{[2
,3
]}

机构：

[1] Katholieke Univ Leuven, Dept Neurosci, Lab Expt Neurosurg & Neuroanat, Leuven, Belgium

[2] Univ Hosp Leuven, Leuven, Belgium

[3] Katholieke Univ Leuven, Dept Microbiol & Immunol, Pediat Oncol, Leuven, Belgium

来源：

2014 6TH INTERNATIONAL ADVANCED RESEARCH WORKSHOP ON IN SILICO ONCOLOGY AND CANCER INVESTIGATION (IARWISOCI) | 2014年

关键词：

REGULATORY T-CELLS; RECURRENT MALIGNANT GLIOMA; TUMOR VACCINATION; EXOGENOUS ANTIGEN; IMMUNE DEFECTS; IMMUNOTHERAPY; RESPONSES; COMBINATION; GENERATION; CHILDREN;

D O I：

暂无

中图分类号：

TM [电工技术]; TN [电子技术、通信技术];

学科分类号：

0808 ; 0809 ;

摘要：

Dendritic cell vaccination is an experimental treatment for malignant gliomas, and has been subject of a translational program for more than ten years in our center. In vitro research, animal models and clinical trials for relapsed and newly diagnosed patients have been conducted. In this paper, we give an overview of the mechanism and rationale of this treatment for brain cancer. We also briefly discuss recently updated results of our clinical trials. Finally, we mention strategies to select patients for this therapy and additional immunotherapeutic strategies to further enhance the antitumor immune responses.

引用

页数：5

共 50 条

[21] Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions
Mollazadeh, Hamid
Mohtashami, Elmira
Mousavi, Seyed H.
Soukhtanloo, Mohammad
Vahedi, Mohammad M.
Hosseini, Azar
Afshari, Amir R.
Sahebkar, Amirhossein
[J]. CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (37) : 4777 - 4788
[22] Boosting Dendritic Cell Vaccination for Glioblastoma Using Tetanus Toxoid
Sonabend, Adam M.
McKhann, Guy M.
[J]. NEUROSURGERY, 2015, 77 (02) : N20 - N21
[23] Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
Datsi, Angeliki
Sorg, Ruediger V.
[J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
[24] CYTOTOXIC T CELL FUNCTIONAL RESPONSIVENESS MAY PREDICT CLINICAL EFFICACY OF DENDRITIC CELL VACCINATION IN GLIOBLASTOMA PATIENTS
Everson, Richard
Jin, Richard
Safaee, Michael
Lisiero, Dominique
Odesa, Sylvia
Liau, Linda
Prins, Robert
[J]. NEURO-ONCOLOGY, 2013, 15 : 69 - 69
[25] GLIOBLASTOMA MULTIFORME - A CLINICAL SURVEY
ROTH, JG
ELVIDGE, AR
[J]. JOURNAL OF NEUROSURGERY, 1960, 17 (04) : 736 - 750
[26] Dramatic clinical response in the treatment of small cell glioblastoma multiforme
Zaman, Farzana Yasmin
McLean, Catriona
Ameratunga, Malaka
[J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 832 - 834
[27] THE IMMUNE LANDSCAPE OF BLOOD DENDRITIC CELLS IN GLIOBLASTOMA MULTIFORME: IMPLICATIONS FOR DC VACCINATION COMBINED WITH CHECKPOINT INHIBITION
Kong, Benjamin
Kim, Julius
Fromm, Phillip
Bui, Kim Tam
Linton, Anthony
Kaufman, Kimberley
Beale, Philip
Buckland, Michael
Clark, Georgina
[J]. NEURO-ONCOLOGY, 2018, 20 : 132 - 132
[28] Advancements in chimeric antigen receptor-expressing T-cell therapy for glioblastoma multiforme: Literature review and future directions
Goutnik, Michael
Iakovidis, Alexandria
Still, Megan E. H.
Moor, Rachel S. F.
Melnick, Kaitlyn
Yan, Sandra
Abbas, Muhammad
Huang, Jianping
Ghiaseddin, Ashley P.
[J]. NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
[29] Pediatric glioblastoma multiforme: A singleinstitution experience
Ansari, Mansour
Nasrolahi, Hamid
Kani, Amir-Abbas
Mohammadianpanah, Mohammad
Ahmadloo, Niloofar
Omidvari, Shapour
Mosalaei, Ahmad
[J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (03) : 155 - 160
[30] Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
Cho, Der-Yang
Yang, Wen-Kuang
Lee, Han-Chung
Hsu, Den-Mei
Lin, Hung-Lin
Lin, Shinn-Zong
Chen, Chun-Chung
Harn, Horng-Jyh
Liu, Chun-Lin
Lee, Wen-Yuan
Ho, Li-Hui
[J]. WORLD NEUROSURGERY, 2012, 77 (5-6) : 736 - 744

← 1 2 3 4 5 →